The Seqens Group, a global manufacturer of health, personal care, and specialty ingredients, recently announced a strategic partnership with Novonesis, a sustainable biological solutions provider.
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
Ecovyst, a provider of advanced materials, specialty catalysts, sulfuric acid and regeneration services, and ChiralVision, a developer of biocatalysis-based technologies have signed a Memorandum of Understanding (MOU) for a partnership in the field of enzyme immobilization.
Aralez Bio, a San Francisco-based start-up, has engineered a platform of enzymes that creates 100 times more compound diversity using processes that are also 50 times greener than conventional methods.
